Similar Articles

AIF1 Gene RS2269475:C>T Polymorphism is Associated With Rheumatoid Arthritis Development but not With Disease Activity

Andrzej PAWLIK, Violetta DZIEDZIEJKO, Mateusz KURZAWSKI, Krzysztof SAFRANOW

DOI: 10.5606/ArchRheumatol.2015.5117

Issue: Volume 30 - Issue 2 - June 2015

6372 4664

Clinical Significance of Combined Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor Assays in Rheumatoid Arthritis Diagnosis

Qingmei CAO, Yanfeng WANG, Yuanyuan JING

DOI: 10.5606/ArchRheumatol.2015.4318

Issue: Volume 30 - Issue 2 - June 2015

9239 4933

Number of Metabolic Syndrome Risk Factors is Related to Carotid Intima-Media Thickness in Rheumatoid Arthritis Patients

Ferhat GÖKMEN, Ahmet TEMİZ, Ayla AKBAL, Hacer ŞEN, Coşkun ZATERİ, Esra GÖKMEN, Emre BOZKURT, Hatice REŞORLU, Tolga KURT, Yılmaz SAVAŞ

DOI: 10.5606/ArchRheumatol.2015.5109

Issue: Volume 30 - Issue 2 - June 2015

6499 4887

Disease Activity (Rheumatoid Arthritis Disease Activity Index-5) in Patients With Rheumatoid Arthritis and its Association With Quality of Life, Pain, Fatigue, and Functional and Psychological Status

İsmihan SUNAR, Yeşim GARİP, Özlem YILMAZ, Hatice BODUR, Şebnem ATAMAN

DOI: 10.5606/ArchRheumatol.2015.5122

Issue: Volume 30 - Issue 2 - June 2015

10558 5992

Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis

Merih BİRLİK, Sedat ÇAPAR, Servet AKAR, İsmail SARI, Fatos ÖNEN, Nurullah AKKOÇ

DOI: 10.5606/ArchRheumatol.2015.5504

Issue: Volume 30 - Issue 3 - September 2015

9307 5122

Association of Plasma Homocysteine Level and Carotid Intima-Media Thickness in Rheumatoid Arthritis Patients Receiving Methotrexate

Emrullah HAYTA, Sami HİZMETLİ, Mehmet Haydar ATALAR, Ziynet ÇINAR

DOI: 10.5606/ArchRheumatol.2015.4249

Issue: Volume 30 - Issue 3 - September 2015

10123 4799

Prevalence of Neuropathic Pain in Rheumatic Disorders: Association With Disease Activity, Functional Status and Quality of Life

Yesim GARİP, Filiz ESER, Ayşegül KILIÇARSLAN, Hatice BODUR

DOI: 10.5606/ArchRheumatol.2015.5295

Issue: Volume 30 - Issue 3 - September 2015

11203 5276

Are We Able to Suppress Disease Activity Adequately in Patients With Established Rheumatoid Arthritis? An Observational and Cross-Sectional Study

İlker ŞENGÜL, Seniz AKÇAY YALBUZDAĞ, Buğra İNCE, Altınay Göksel KARATEPE, Taciser KAYA

DOI: 10.5606/ArchRheumatol.2016.5704

Issue: Volume 31 - Issue 2 - June 2016

5491 5139

Turkish Compliance and Adaptation of EULAR 2013 Recommendations for the Management of Rheumatoid Arthritis with Synthetic and Biological Disease-Modifying Antirheumatic Drugs: Expert Opinion of TLAR

Şebnem ATAMAN, Zühre SARI SÜRMELİ, İsmihan SUNAR, Erhan ÖZDEMİREL, Ayşen AKINCI, Hatice BODUR, Özgür AKGÜL, Lale ALTAN, Zuhal ALTAY, Figen AYHAN, Murat BİRTANE, Derya SOY BUĞDAYCI, Erhan ÇAPKIN, Lale CERRAHOĞLU, Mehmet Tuncay DURUÖZ, Rezzan GÜNAYDIN, Zafer GÜNENDİ, Gülcan GÜRER, Ajda BAL, Cahit KAÇAR, Ece KAPTANOĞLU, Taciser KAYA, Hilal KOCABAŞ, Nurdan KOTEVOĞLU, Kemal NAS, Aylin REZVANİ, Nesrin ŞEN, Ömer Faruk ŞENDUR, Peyman YALÇIN

DOI: 10.5606/ArchRheumatol.2015.5654

Issue: Volume 30 - Issue 4 - December 2015

10702 5709